Of importance, there was a highly significant and consistent association between a marked increase in overall patient survival, the value of the mean score of the GES, and the presence of TL-TLSs in stage IV (non-locoregional) melanoma, colorectal cancer, and, most recently, in stage IV bladder cancer, non-small cell lung cancer, and certain types of breast cancer, especially in basal and HER2 + patients.
← all excerpts
Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering.
1
—
—